Setting
Clinical practices of glaucoma specialists and comprehensive ophthalmologists.
Summary and Conclusion
Combined ECP-cataract extraction resulted in lower IOP and greater reduction in glaucoma medications than cataract extraction alone in medically controlled open angle glaucoma patients with visually significant cataract. Baseline IOP = 18.1 mm Hg, 3 year IOP ECP/PE = 15.4 with <1 med, 3 year PE alone = 17.2 with 2 meds.
Endoscopic Cyclophotocoagulation Combined With Phacoemulsification vs. Phacoemulsification Alone in Medically Controlled Glaucoma Results
The difference in IOP and medication reduction between the 2 groups was statistically significant at all time points. Visual acuity outcomes and complication rates were similar between the 2 groups.
Design
Prospective nonrandomized matched-control study.
Methods
80 Consecutive patients were treated with ECP and cataract extraction (study group) or cataract extraction alone (control group). The groups were matched in age and baseline intraocular pressure (IOP). The main outcome measures were the change in IOP and number of glaucoma medications. Secondary measures included visual acuity and postoperative complications. 
BASELINE

Design
Retrospective nonrandomized study comparing data from consecutive patients who underwent 1-site (group 1) vs. 2-site (group 2) PE-ECP. Patients were selected for each group, equivalent in age, baseline IOP and number of medications.
Summary and Conclusion
IOP data at 6 months showed that 2-site clear corneal incision during PE-ECP may result in statistically significant lower IOP, and less dependence on glaucoma meds versus 1-site. One-site treated between 240°-300°, 2-site treated 360°.
One 
Methods
Phacoemulsification was completed with in the bag placement of a posterior chamber IOL. Visco was then used underneath the iris to improve visualization of the ciliary processes. ECP was done using a curved probe. In the case of the single clear corneal incision, up to 300° was treated. With two incisions, 360° was treated. Irrigation/aspiration was then used to remove iscoelastic from the anterior chamber, the eye was pressurized with balanced salt solution, and the incisions were hydrated closed. 
Change in IOP From
10: EASY TO DO
Adds only 2-4 minutes to the procedure.
9: TITRATABLE
No reports of hypotony or phthisis as a primary procedure with more than 1,000 cases with 5 years' follow-up and more than 50,000 cases worldwide in the past 10 years.
8: REPEATABLE
Can treat full 360° because the tips of the ciliary processes are treated, sparing the valleys in between.
7: VALUE ADDED FOR PATIENTS
Phaco-ECP is proven to further decrease IOP and the number of meds than phaco alone.
6: NO ADDITIONAL PATIENT FOLLOW UPS
Patients only need to be seen the same as phaco procedures alone post operatively, 1d, 1wk, 1m. 
"ECP is fun and interesting -
4: CONJUCTIVA IS LEFT UNDISTURBED
If necessary, selective laser trabeculoplasty, repeat ECP, trabeculectomy or glaucoma drainage devices can be done subsequently.
3: NO EARLY OR LATE COMPLICATIONS
Unlike trabeculectomy or shunt procedures.
2: REIMBURSEABLE
In the US, CPT Code 06711 more than covers costs associated with the procedure for both surgeon and facility.
1: ECP IS FUN AND INTERESTING!
A new view for surgeons, revealing a different look at cataracts, pathologic ciliary processes, zonules, capsular defects, etc. • Treat the entire ciliary process from top to bottom, as well as the spaces between.
TOP TEN REASONS to Perform Combined Phaco-ECP
• Eyes with pseudoexfoliation are more difficult to treat and may require an increase in laser power, or moving the probe closer to the target tissue.
• Remove all OVD inside the eye after the procedure, including in front and behind the iris, as well as behind the IOL.
• Treat all patients with a topical glaucoma med and oral acetazolamide 500mg immediately after surgery. Monitor patients for postop IOP spikes within the first 24 hours and as early as 3 hours post op.
• Taper glaucoma meds if IOP is reduced from pre-operative level. It may take 4-6 weeks to see the full effect of ECP.
• Some Phaco-ECP patients appear exactly the same as phaco alone and can be treated with the standard regimen of topical steroid and NSAID four times daily for 2-3 wks. Other phaco-ECP patients may exhibit increased inflammation and should be treated more intensively with anti-inflammatory agents for a slightly longer period.
